Literature DB >> 30151891

Glucose metabolism and metabolic flexibility in blood platelets.

M Aibibula1, K M Naseem2, R G Sturmey1.   

Abstract

Essentials The metabolic integration processes required for platelet activation are unclear. The metabolic plasticity of human platelets were investigated. Activated platelets exhibit a glycolytic phenotype while preserving mitochondrial function. Platelets can switch freely between glucose/glycogen and fatty acids to support aggregation.
SUMMARY: Background Platelet activation is an energy-dependent process, but the type and integrated use of metabolic fuels required to drive activation remain unclear. Objective To dissect the metabolic fuel and pathway plasticity required for platelet activation. Methods Platelet oxygen consumption rate and extracellular acidification rate were measured as markers of oxidative phosphorylation (OXPHOS) and glycolysis, respectively. Glucose and glycogen were quantified by enzyme-coupled fluorometric assay. Results Blood platelets switched freely between glycolysis and OXPHOS, using either glucose or fatty acids at rest. The transition of platelets from a quiescent to an activated state promoted rapid uptake of exogenous glucose, associated with a shift to a predominantly glycolytic phenotype coupled with a minor rise in mitochondrial oxygen consumption. Consistent with this metabolic plasticity, under nutrient-limiting conditions, platelets utilized glucose, glycogen or fatty acids independently to support activation. Importantly, the glycolytic switch occurred even in the absence of extracellular glucose, originating from endogenous glycogen. Focusing on the relative flexibility of mitochondrial fuel oxidation of glucose and fatty acids, we found that inhibition of oxidation of a single fuel was compensated for by increased oxidation of the other, but, when oxidation was inhibited, glycolysis was upregulated. Glutamine made little contribution to mitochondrial oxygen consumption. Analysis of platelet functional dependency on ATP from different pathways demonstrated that inhibition of both fuel oxidation and glycolysis were required to prevent agonist-driven platelet activation. Conclusion Platelets have significant metabolic fuel and pathway flexibility, but preferentially use glycolysis for ATP generation when activated.
© 2018 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  blood platelets; fatty acids; glycogen; glycolysis; oxidative phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 30151891     DOI: 10.1111/jth.14274

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  20 in total

1.  Platelet respiration.

Authors:  Andaleb Kholmukhamedov; Shawn Jobe
Journal:  Blood Adv       Date:  2019-02-26

2.  Inhibition of mitochondrial complex I leading to NAD+/NADH imbalance in type 2 diabetic patients who developed late stent thrombosis: Evidence from an integrative analysis of platelet bioenergetics and metabolomics.

Authors:  Mi-Jie Gao; Ning-Hua Cui; Xia'nan Liu; Xue-Bin Wang
Journal:  Redox Biol       Date:  2022-10-11       Impact factor: 10.787

3.  Inorganic Polyphosphate, Mitochondria, and Neurodegeneration.

Authors:  Pedro Urquiza; Maria E Solesio
Journal:  Prog Mol Subcell Biol       Date:  2022

4.  Chronic Immune Platelet Activation Is Followed by Platelet Refractoriness and Impaired Contractility.

Authors:  Izabella A Andrianova; Alina I Khabirova; Anastasia A Ponomareva; Alina D Peshkova; Natalia G Evtugina; Giang Le Minh; Timur B Sibgatullin; John W Weisel; Rustem I Litvinov
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 5.  Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches.

Authors:  Jessica F Hebert; Leslie Myatt
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-10       Impact factor: 5.187

6.  Isotopically nonstationary 13C metabolic flux analysis in resting and activated human platelets.

Authors:  Cara L Sake; Alexander J Metcalf; Michelle Meagher; Jorge Di Paola; Keith B Neeves; Nanette R Boyle
Journal:  Metab Eng       Date:  2021-12-22       Impact factor: 9.783

7.  Co-expression analysis to identify key modules and hub genes associated with COVID-19 in platelets.

Authors:  Ahmed B Alarabi; Attayeb Mohsen; Kenji Mizuguchi; Fatima Z Alshbool; Fadi T Khasawneh
Journal:  BMC Med Genomics       Date:  2022-04-14       Impact factor: 3.622

8.  Fatal dysfunction and disintegration of thrombin-stimulated platelets.

Authors:  Oleg V Kim; Tatiana A Nevzorova; Elmira R Mordakhanova; Anastasia A Ponomareva; Izabella A Andrianova; Giang Le Minh; Amina G Daminova; Alina D Peshkova; Mark S Alber; Olga Vagin; Rustem I Litvinov; John W Weisel
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

Review 9.  Role of Platelet Mitochondria: Life in a Nucleus-Free Zone.

Authors:  Hannah Melchinger; Kanika Jain; Tarun Tyagi; John Hwa
Journal:  Front Cardiovasc Med       Date:  2019-10-29

10.  Peculiarities of Platelet Metabolism in Patients with Acute Coronary Syndrome with Anxiety-Depressive Disorders and Informativity of Enzymes in the Forecast of Development of Cardiovascular Complications.

Authors:  Natalya Yu Shimokhina; Andrey A Savchenko; Marina M Petrova
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.